User profiles for Giuseppe Vittorio De Socio

Giuseppe Vittorio De Socio

Clinica di Malattie Infettive, Azienda Ospedaliero-Universitaria di Perugia. Ospedale "Santa …
Verified email at ospedale.perugia.it
Cited by 3314

Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection

…, GV De Socio, S Sabbatini, D Francisci - Infectious …, 2020 - Taylor & Francis
Background: From January 2020, Coronavirus disease 19 (COVID-19) has rapidly spread
all over the world. An early assessment of illness severity is important for the stratification of …

Effect of high-titer convalescent plasma on progression to severe respiratory failure or death in hospitalized patients with COVID-19 pneumonia: a randomized clinical …

…, G Tiseo, A Bartoloni, GV De Socio… - JAMA network …, 2021 - jamanetwork.com
Importance Convalescent plasma (CP) has been generally unsuccessful in preventing
worsening of respiratory failure or death in hospitalized patients with COVID-19 pneumonia. …

Weight gain: a possible side effect of all antiretrovirals

…, G Madeddu, CV Martinelli, GV De Socio… - Open forum …, 2017 - academic.oup.com
Weight gain and body mass index (BMI) increase are central issues in patients living with
HIV who need to minimize the risk of metabolic disease. Information collected through the …

Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study

GV De Socio, E Ricci, P Maggi, G Parruti… - American journal of …, 2014 - academic.oup.com
BACKGROUND We aimed to assess the prevalence of hypertension in an unselected human
immunodeficiency virus (HIV)–infected population and to identify factors associated with …

Factors associated with weight gain in people treated with dolutegravir

…, N Squillace, B Menzaghi, GV De Socio… - Open Forum …, 2020 - academic.oup.com
Background An unexpected excess in weight gain has recently been reported in the course
of dolutegravir (DTG) treatment. The aim of the present study was to investigate whether …

Laboratory Automation, Informatics and Artificial Intelligence: current and future perspectives in clinical microbiology

A Mencacci, GV De Socio, E Pirelli, P Bondi… - Frontiers in Cellular …, 2023 - frontiersin.org
Clinical diagnostic laboratories produce one product – information – and for this to be
valuable, the information must be clinically relevant, accurate, and timely. Although diagnostic …

[HTML][HTML] Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a …

…, B Menzaghi, N Squillace, GV De Socio… - BMC Infectious …, 2018 - Springer
Background Dyslipidemia represents a significant non-infectious comorbidity among people
living with HIV. The aim of this study is to evaluate the impact on lipid profile of switches …

[HTML][HTML] Causes of HIV treatment interruption during the last 20 years: a multi-cohort real-life study

…, CV Martinelli, N Squillace, L Taramasso, GV De Socio… - Viruses, 2023 - mdpi.com
In the last years, many antiretroviral drugs (ART) have been developed with increased
efficacy. Nowadays, the main reasons for treatment switches are adverse events, proactive …

Durability of dolutegravir-based regimens: a 5-year prospective observational study

…, C Molteni, R Gulminetti, GV De Socio… - AIDS Patient Care …, 2021 - liebertpub.com
This study evaluates the frequency and causes of dolutegravir (DTG) discontinuation along
5 years of follow-up, in both antiretroviral treatment (ART)-naive and experienced people …

[HTML][HTML] National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study

GV De Socio, A Gidari, F Sicari, M Palumbo… - Infection, 2021 - Springer
Purpose Clinical scores to rapidly assess the severity illness of Coronavirus Disease 2019 (COVID-19)
could be considered of help for clinicians. Recently, a specific score (named …